Tadocizumab (anti-Integrin α2β3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183432-100ΜG / 100ΜG
CAS:339086-80-5
Tadocizumab (anti-Integrin α2β3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183432-10MG / 10MG
CAS:339086-80-5
Tadocizumab (anti-Integrin α2β3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183432-1MG / 1MG
CAS:339086-80-5
Tadocizumab (anti-Integrin α2β3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183432-5MG / 5MG
CAS:339086-80-5
Tenatumomab (anti-Tenascin C) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183433-100ΜG / 100ΜG
CAS:1412891-40-7
Tenatumomab (anti-Tenascin C) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183433-10MG / 10MG
CAS:1412891-40-7
Tenatumomab (anti-Tenascin C) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183433-1MG / 1MG
CAS:1412891-40-7
Tenatumomab (anti-Tenascin C) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183433-5MG / 5MG
CAS:1412891-40-7
Vesencumab (anti-NRP1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183435-100ΜG / 100ΜG
CAS:1205533-60-3
Vesencumab (anti-NRP1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183435-10MG / 10MG
CAS:1205533-60-3
Vesencumab (anti-NRP1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183435-1MG / 1MG
CAS:1205533-60-3
Vesencumab (anti-NRP1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183435-5MG / 5MG
CAS:1205533-60-3
Zalutumumab (anti-EGFR) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183436-100ΜG / 100ΜG
CAS:667901-13-5
Zalutumumab (anti-EGFR) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183436-10MG / 10MG
CAS:667901-13-5
Zalutumumab (anti-EGFR) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183436-1MG / 1MG
CAS:667901-13-5
Zalutumumab (anti-EGFR) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183436-5MG / 5MG
CAS:667901-13-5
Matuzumab (anti-EGFR) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183438-100ΜG / 100ΜG
CAS:339186-68-4
Matuzumab (anti-EGFR) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183438-10MG / 10MG
CAS:339186-68-4
Matuzumab (anti-EGFR) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183438-1MG / 1MG
CAS:339186-68-4
Matuzumab (anti-EGFR) Carrier Free, 重組, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183438-5MG / 5MG
CAS:339186-68-4
Teneliximab (anti-CD40) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183440-100ΜG / 100ΜG
CAS:299423-37-3
Teneliximab (anti-CD40) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183440-10MG / 10MG
CAS:299423-37-3
Teneliximab (anti-CD40) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183440-1MG / 1MG
CAS:299423-37-3
Teneliximab (anti-CD40) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183440-5MG / 5MG
CAS:299423-37-3
Faralimomab (anti-IFNAR-1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183441-100ΜG / 100ΜG
CAS:167816-91-3
Faralimomab (anti-IFNAR-1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183441-10MG / 10MG
CAS:167816-91-3
Faralimomab (anti-IFNAR-1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183441-1MG / 1MG
CAS:167816-91-3
Faralimomab (anti-IFNAR-1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183441-5MG / 5MG
CAS:167816-91-3
Metelimumab (anti-TGFb1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183442-100ΜG / 100ΜG
CAS:272780-74-2
Metelimumab (anti-TGFb1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183442-10MG / 10MG
CAS:272780-74-2
Metelimumab (anti-TGFb1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183442-1MG / 1MG
CAS:272780-74-2
Metelimumab (anti-TGFb1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183442-5MG / 5MG
CAS:272780-74-2
Mapatumumab (anti-TNFRSF10A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183444-100ΜG / 100ΜG
CAS:658052-09-6
Mapatumumab (anti-TNFRSF10A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183444-10MG / 10MG
CAS:658052-09-6
Mapatumumab (anti-TNFRSF10A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183444-1MG / 1MG
CAS:658052-09-6
Mapatumumab (anti-TNFRSF10A) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183444-5MG / 5MG
CAS:658052-09-6
Toralizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183447-100ΜG / 100ΜG
CAS:252662-47-8
Toralizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183447-10MG / 10MG
CAS:252662-47-8
Toralizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183447-1MG / 1MG
CAS:252662-47-8
Toralizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183447-5MG / 5MG
CAS:252662-47-8
Ruplizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183448-100ΜG / 100ΜG
CAS:220651-94-5
Ruplizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183448-10MG / 10MG
CAS:220651-94-5
Ruplizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183448-1MG / 1MG
CAS:220651-94-5
Ruplizumab (anti-CD40L) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183448-5MG / 5MG
CAS:220651-94-5
Enlimomab (anti-ICAM1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183449-100ΜG / 100ΜG
CAS:142864-19-5
Enlimomab (anti-ICAM1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183449-10MG / 10MG
CAS:142864-19-5
Enlimomab (anti-ICAM1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183449-1MG / 1MG
CAS:142864-19-5
Enlimomab (anti-ICAM1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183449-5MG / 5MG
CAS:142864-19-5
Erlizumab (anti-CD18) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183450-100ΜG / 100ΜG
CAS:211323-03-4
Erlizumab (anti-CD18) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183450-10MG / 10MG
CAS:211323-03-4